ABOUT THIS FUND
The Horizon Kinetics Medical ETF (the “Fund”) seeks long-term growth of capital. The Fund is an actively-managed exchange-traded fund (“ETF”) that will invest primarily in patented first line pharmaceuticals and biologics as these products tend to have high profit margins and significant barriers to entry. The Fund employs a long-term perspective, seeking to capture returns of both intrinsic valuation realization and scientific discovery.
PRICE
$36.56 ▼ DOWN 0.84% (−$0.31)HOLDINGS
TOP 20 OF 30 · 88.01% OF THE FUNDRANK STOCK WEIGHT SHARES VALUE
